NEXEL Co.
Latest round
- Series B
Last raised
- Sep 2019
Total raised
- $8.9M
Investors
- 10
About NEXEL Co.
, Ltd., Ltd. develops innovative iPSC-derived cell products.327 mn.NEXEL specializes in developing human induced pluripotent stem cell (iPSC)-derived cell products. Their offerings include various cell types used in research and therapeutic applications in drug discovery, regenerative medicine, and disease modeling., Ltd. The company is targeting expansion into new geographic markets, such as Asia and North America, by 2025 to enhance their sales capabilities.
Who invested in NEXEL Co.
10 investors across 4 rounds
See all investors in NEXEL Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NEXEL Co.
Who invested in NEXEL Co.?
NEXEL Co. has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NEXEL Co. raised?
NEXEL Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did NEXEL Co. last raise money?
NEXEL Co.'s most recent round on record is a Series B, in Sep 2019.
What does NEXEL Co. do?
NEXEL Co. is a biotechnology company.
Where is NEXEL Co. headquartered?
NEXEL Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like NEXEL Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at NEXEL Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like NEXEL Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.